Every SEC Form 3/4/5 on record for this filer (CIK 1669816) — 5 issuers, 12 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| INVA | Innoviva, Inc. | Director | 2018-02-14 → 2026-05-06 | 11 | — |
| OIM | OneIM Acquisition Corp. | Director | 2026-01-13 → 2026-01-13 | 1 | — |
| AMRN | AMARIN CORP PLC\UK | Director | 2023-03-10 → 2025-04-22 | 4 | — |
| SRSA | Sarissa Capital Acquisition Corp. | Senior Managing Director · lapsed | 2020-10-20 → 2020-10-20 | 1 | — |
| NVLN | NOVELION THERAPEUTICS INC. | Director · lapsed | 2017-08-02 → 2018-08-13 | 3 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
2 of 5 issuers are covered and open a security page; the rest are on file here only.